What Is GLP-1 Really Doing in Obesity?

Publication date: Available online 18 October 2019Source: Trends in Endocrinology & MetabolismAuthor(s): Tohru Hira, Jukkrapong Pinyo, Hiroshi HaraGlucagon-like peptide-1 (GLP-1) is a gastrointestinal hormone released in response to meal ingestion and enhances insulin secretion from pancreatic β cells. In several human studies, GLP-1 secretory responses to oral glucose load or a meal were decreased in subjects with obesity, glucose intolerance, or diabetes compared with those in healthy subjects. However, the results of meta-analysis and cohort studies do not necessarily support this concept. Results from animal studies are also inconsistent; in multiple studies, GLP-1 secretory responses to a meal were repeatedly higher in diet-induced obese rats than in control rats. Thus, the postprandial GLP-1 response is not necessarily decreased but rather enhanced during obesity development, which is likely to play a protective role against glucose intolerance.
Source: Trends in Endocrinology and Metabolism - Category: Endocrinology Source Type: research